H-Index
79
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
15%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo

Medical Science Monitor Basic Research
AmJCaseRep

Annals
ISI-Home

eISSN: 1643-3750

Short Hairpin Ribonucleic Acid Constructs Targeting Insulin-Like Growth Factor Binding Protein-3 Rehabilitated Decreased Testosterone Concentrations in Diabetic Rats

Zhang-Yan Zhou, Fei Li, Shao-Ping Cheng, Hui Huang, Bi-Wen Peng, Jing Wang, Chang-Mao Liu, Cheng Xing, Ya-Ling Sun, Najeeb Bsoul, Hui Pan, Cun-Jian Yi, Rong-Hua Liu, Guang-Jun Zhong

Department of Urology, First Affiliated Hospital of Yangtze University, Jingzhou, China (mainland)

Med Sci Monit 2015; 21:94-99

DOI: 10.12659/MSM.891382

Available online:

Published: 2015-01-08


#891382

Background: The aim of this study was to determine if shRNA constructs targeting insulin-like growth factor binding protein-3 can rehabilitate decreased serum testosterone concentrations in streptozotocin-induced diabetic rats.
Material and Methods: After 12 weeks of intracavernous administration of IGFBP-3 shRNA, intracavernous pressure responses to electrical stimulation of cavernous nerves were evaluated. The expression of IGFBP-3 at mRNA and protein levels was detected by quantitative real-time PCR analysis and Western blot, respectively. The concentrations of serum testosterone and cavernous cyclic guanosine monophosphate were detected by enzyme-linked immunosorbent assay.
Results: After 12 weeks of intracavernous administration of IGFBP-3 shRNA, the cavernosal pressure was significantly increased in response to the cavernous nerves stimulation compared to the diabetic control group (p<0.01). Cavernous IGFBP-3 expression at both mRNA and protein levels was significantly inhibited. Both serum testosterone and cavernous cyclic guanosine monophosphate concentrations were significantly increased in the IGFBP-3 shRNA treatment group compared to the diabetic control group (p<0.01).
Conclusions: These results suggest that IGFBP-3 shRNA may rehabilitate erectile function via increases of concentrations of serum testosterone and cavernous cyclic guanosine monophosphate in streptozotocin-induced diabetic rats.

Keywords: Cyclic GMP - metabolism, Animals, Diabetes Mellitus, Experimental - blood, Diabetes Mellitus, Type 1 - blood, Electric Stimulation, Enzyme-Linked Immunosorbent Assay, Erectile Dysfunction - therapy, Insulin-Like Growth Factor Binding Protein 3 - metabolism, Methyltestosterone - blood, RNA, Messenger - metabolism, RNA, Small Interfering - metabolism, Rats, Rats, Wistar, Real-Time Polymerase Chain Reaction - methods, Signal Transduction, Testosterone - blood



Back